聚焦艾昆纬-中东和非洲制药业务洞察(英)-2026。Value sales growth has been at 13.62% PPG1(Previous Period Growth) and 12.15% CAGR2 while Volume sales has increased at 6.24% PPG &at 2.33% CAGR2;Hikma is leading the business with 8.48% share, sales has increased by 4.9% in MAT Q4 2025. J.P.M. has registered fastest growth of 22.9% PPG among the top 10 corporations。
聚焦艾昆纬-中东和非洲制药业务洞察(英)-2026。Value sales growth has been at 13.62% PPG1(Previous Period Growth) and 12.15% CAGR2 while Volume sales has increased at 6.24% PPG &at 2.33% CAGR2;Hikma is leading the business with 8.48% share, sales has increased by 4.9% in MAT Q4 2025. J.P.M. has registered fastest growth of 22.9% PPG among the top 10 corporations。
聚焦艾昆纬-中东和非洲制药业务洞察(英)-2026。Value sales growth has been at 13.62% PPG1(Previous Period Growth) and 12.15% CAGR2 while Volume sales has increased at 6.24% PPG &at 2.33% CAGR2;Hikma is leading the business with 8.48% share, sales has increased by 4.9% in MAT Q4 2025. J.P.M. has registered fastest growth of 22.9% PPG among the top 10 corporations。
覆盖 2026 年,全文共 29 页。
本报告为付费报告,可在资料宝站内下单后获取完整内容。
重点分析了制药、艾昆纬、中东和非洲制药业务洞察等议题。